134 related articles for article (PubMed ID: 12186527)
1. Infliximab therapy for complicated sarcoidosis.
Cook MC
Ann Intern Med; 2002 Aug; 137(4):296-7; author reply 296-7. PubMed ID: 12186527
[No Abstract] [Full Text] [Related]
2. Infliximab therapy for complicated sarcoidosis.
O'Connor TM; Shanahan F; Bredin CP
Ann Intern Med; 2002 Aug; 137(4):296-7; author reply 296-7. PubMed ID: 12186528
[No Abstract] [Full Text] [Related]
3. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.
Yee AM; Pochapin MB
Ann Intern Med; 2001 Jul; 135(1):27-31. PubMed ID: 11434729
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. A new anti-inflammatory therapy (Infliximab) for complicated sarcoidosis.
Ann Intern Med; 2001 Jul; 135(1):S20. PubMed ID: 11462996
[No Abstract] [Full Text] [Related]
5. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of sarcoidosis.
Ali Y; Perlman E
Ann Intern Med; 2004 Jun; 140(11):W70. PubMed ID: 15172930
[No Abstract] [Full Text] [Related]
7. Infliximab treatment of sarcoidosis.
Serio RN
Ann Pharmacother; 2003 Apr; 37(4):577-81. PubMed ID: 12659618
[TBL] [Abstract][Full Text] [Related]
8. Refractory sarcoidosis responding to infliximab.
Roberts SD; Wilkes DS; Burgett RA; Knox KS
Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
[TBL] [Abstract][Full Text] [Related]
9. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.
Ulbricht KU; Stoll M; Bierwirth J; Witte T; Schmidt RE
Arthritis Rheum; 2003 Dec; 48(12):3542-3. PubMed ID: 14674007
[TBL] [Abstract][Full Text] [Related]
10. Infliximab therapy for sarcoidosis (lupus pernio).
Haley H; Cantrell W; Smith K
Br J Dermatol; 2004 Jan; 150(1):146-9. PubMed ID: 14746631
[TBL] [Abstract][Full Text] [Related]
11. [Nasosinusal and cervical sarcoidosis: a case series of three patients and literature review].
Hermet M; le Guenno G; Rieu V; Philippe P; Ruivard M
Rev Med Interne; 2012 Jan; 33(1):46-9. PubMed ID: 21601318
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sarcoidosis with infliximab.
Doty JD; Mazur JE; Judson MA
Chest; 2005 Mar; 127(3):1064-71. PubMed ID: 15764796
[TBL] [Abstract][Full Text] [Related]
13. Refractory vertebral sarcoidosis responding to infliximab.
Garg S; Garg K; Altaf M; Magaldi JA
J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.
Baughman RP; Lower EE; Drent M
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):76-89. PubMed ID: 19382527
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy.
Baughman RP; Iannuzzi M
BioDrugs; 2003; 17(6):425-31. PubMed ID: 14614765
[TBL] [Abstract][Full Text] [Related]
16. [The role of tumor necrosis factor in pathogenesis and treatment of sarcoidosis].
Vizel' AA; Guryleva ME; Vizel' EA; Nasretdinova GP
Klin Med (Mosk); 2003; 81(9):4-8. PubMed ID: 14598582
[No Abstract] [Full Text] [Related]
17. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients.
Pritchard C; Nadarajah K
Ann Rheum Dis; 2004 Mar; 63(3):318-20. PubMed ID: 14962969
[TBL] [Abstract][Full Text] [Related]
19. Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale.
Sorrentino D; Avellini C; Zearo E
Inflamm Bowel Dis; 2004 Jul; 10(4):438-40. PubMed ID: 15475755
[TBL] [Abstract][Full Text] [Related]
20. Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab.
Fang B; Bhagat S; Busch R; Parfrey H; Hall FC
Rheumatology (Oxford); 2011 May; 50(5):992-4. PubMed ID: 21278065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
